Interventional techniques for the treatment of head and neck pain

References

• Hu X, Markson L, Lipton R, Stewart W Berger M. Burden of Migraine in the United States: disability and economic costs. Arch. Intern. Med. 159(8), 813–818 (1999).
   Google Scholar
• Saberski L, Fitzgerald J, Ahmad M. Cryoneurolysis and Radiofrequency Lesioning. In: Practical Management of Pain Thin] Edition. Raj P (Ed.), Mosby Inc., MO, USA, 753–767 (2000).
   Google Scholar
• Higuchi Y, Nashold BS, Sluijter M, Cosman E, Pearlstein RD. Exposure of the dorsal root ganglion in rats to pulsed radiofrequency activates dorsal horn lamina I and II neurons. Neurosurgery 50(4), 850–855 (2002).
   Google Scholar
• Sluijter M, van Kleef M. Characteristics and mode of action of radiofrequency lesioning. CUI7: Rev Pain 2,143-150 (1998). Reviews the concept and mechanism of pulsed radiofrequency which is becoming a therapeutic option for nerve rhizotomy.
   Google Scholar
• Claeys L. Vascular pain in patients with chronic, critical limb ischaemia. C1.117: Rev Pain 1,371–377 (1997).
   Google Scholar
• Freund B, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin: a pilot study. Headache 40(3), 231–236 (2000).
   PubMed Web of Science ®Google Scholar
• Weiner R, Reed K. Peripheral neurostimulation for control of intractable occipital neuralgia. Neummoduktion 3, 217–221 (1999).
   Google Scholar
• Cluff R, Mehio A, Cohen S etal The technical aspects of epidural steroid injections: a national survey. Anesth. Anal& 95(2), 403–408 (2002).
   Google Scholar
• Stojanovic M, Vu T, Caneris O et al The role of fluoroscopy in cervical epidural steroid injections: an analysis of contrast dispersal patterns. Soine27(5), 509–514 (2002).
   Google Scholar
• Klein G, Vaccaro A, Cwik J eta]. Efficacy of cervical epidural steroids in the treatment of cervical spine disorders. Am. Anesthesia]: 9,547-550 (2000).
   Google Scholar
• Slosar P, White A, Wetzel E Controversy: The Use of Selective Nerve Root Blocks: Diagnostic, Therapeutic, or Placebo? Spine 23(20), 2253–2256 (1998).
   Google Scholar
• Link S, El-Khoury G, Guilford W Percutaneous epidural and nerve root block and percutaneous lumbar sympatholysis. Radiologic Gun. N Am. 36(3), 509–521 (1998).
   Google Scholar
• Day M. Nerve Root Neurolysis. In:Textbook of Regional Anesthesia. Raj P (Ed.). Churchill Livingston, PA, USA, 733–746 (2002).
   Google Scholar
• Slipman C, Lipetz J, Jackson H eta]. Therapeutic selective nerve root block in the nonsurgical treatment of atraumatic cervical spondylotic radicular pain: a retrospective analysis with independent clinical review. Arch. Phys. Med. Rehabil 81,741–746 (2000).
   Google Scholar
• Van Med' M, Liem L, Lousberg R, Barendse G, Kessels F, Sluijter M. Radiofrequency lesion adjacent to the dorsal root ganglion for cervicobrachial pain; a prospective double-blind randomized study. Neurosurgery 38(6), 1127–1131 (1996).
   Google Scholar
• Van Med' M, Suijlekom J. Treatment of chronic cervical pain, brachialgia and cervicogenic headache by means of radiofrequency procedures. Pain Practice 2(3), 214–223 (2002).
   Google Scholar
• Brouwers P, Kottink E, Simon M, Prevo R. A cervical anterior spinal artery syndrome after diagnostic blockade of the right C6 nerve root. Pain 91(3), 217–218 (2001)
   Google Scholar
• •Illustrates the severity of complications that can occur with cervical root sleeve injections.
   Google Scholar
• Slipman C, Lipetz J, Plastaras C eta]. Therapeutic zygapophyseal joint injections for headaches emanating from the C2-3 joint. Ainj Phys. Med. Rehabil 80(3), 182–188 (2001).
   Google Scholar
• McDonald G, Lord S, Bogduk N. Long- term follow-up of patients treated with cervical neurotomy for chronic neck pain. Neurosurgery 45 (1), 61–68 (1999).
   PubMed Web of Science ®Google Scholar
• Van Suijlekom H, van Kleef M, Barendse G, Sluijter M, Sjaastad O, Weber W Radiofrequency cervical zygapophyseal joint neurotomy for cervicogenic headache: a prospective study of 15 patients. Funct. Neural. 13(4), 297–303 (1998).
   Google Scholar
• Glemarec J, Guillot P, Laborie Y, Berthelot J, Prost A, Maugars Y. Intraarticular glucocorticosteroid injection into the lateral atlantoaxial joint under fluoroscopic control. A retrospective comparative study in patients with mechanical and inflammatory disorders. Joint Bone Spine 67(1), 54–61 (2000).
   Google Scholar
• Forouzanfar T, van Kleef M, Weber W Radiofrequency lesions of the stellate ganglion in chronic pain syndromes: retrospective analysis of clinical efficacy in 86 patients. Clin. Pain 16(2), 164–168 (2000).
   Google Scholar
• Day M, Racz G. Sphenopalatine Ganglion Blockade. In: Interventional Pain Management Second Edition. Waldman S (Ed.), WB Saunders, PA, USA, 307–311, (2001).
   Google Scholar
• Sanders M, Zuurmond W Efficacy of sphenopalatine ganglion blockade in 66 patients suffering from cluster headaches: a 12- to 70-month follow-up evaluation.j Neurosurg. 87 (6), 876–880 (1997).
   Google Scholar
• •Illustrates the effectiveness of sphenopalatine ganglion blockade for treating refractory cluster headches.
   Google Scholar
• Scrivani S, Keith D, Mathews E, Kaban L. Percutaneous stereotactic differential radiofrequency thermal rhizotomy for the treatment of trigeminal neuralgia. I Oral Maxillofac. Surg. 57,104–111 (1999).
   PubMed Web of Science ®Google Scholar
• Yoon K, Wiles J, Miles J, Nurmikko T Long-term outcome of percutaneous thermocoagulation for trigeminal neuralgia. Anaesthesia 54,798–808 (1999).
   Web of Science ®Google Scholar
• Mizuno M, Saito K, Takayasu M, Yoshida J. Percutaneous microcompression of the trigeminal ganglion for elderly patients with trigeminal neuralgia and patients with atypical trigeminal neuralgia. Neuro. Med. Chin 40,347–350 (2000).
   Google Scholar
• Urculo E, Arrazola M, Gereka L et al Evaluation of the Mullan's technique in the treatment of trigeminal neuralgia. Rev Neural. 27,477–484 (1998).
   Google Scholar
• Pradel W, Hlawitschka M, Eckelt U, Herzog R, Koch K. Cryosurgical treatment of genuine trigeminal neuralgia. BE j Oral Maxillofac. Surg. 40(3), 244–247 (2002).
   Google Scholar
• Racz G, Heavner J, Raj P. Percutaneous epidural neuroplasty: Prospective one-year follow-up. Pain Digest9, 97–102 (1999). Documents the effectiveness of epidural decompressive neuroplasty.
   Google Scholar
• Day M. Neuromodulation: spinal cord and peripheral nerve stimulation. C1.117: Rev Pain 4,374–382 (2000).
   Google Scholar
• Barolat G, Sharan A. Future trends in spinal cord stimulation. Neurological Res. 22,279–284 (2000).
   PubMed Web of Science ®Google Scholar
• Deer T Current and future trends in spinal cord stimulation for chronic pain. CI.117: Pain Headache Rep. 5(6), 503–509 (2001).
   Google Scholar
• Linderoth B, Foreman R. Physiology of spinal cord stimulation: review and update. Neuromodulation 2,150–164 (1999).
   PubMed Web of Science ®Google Scholar
• Cui G, O'Conner W, Ungerstedt U et al Spinal cord stimulation attenuates dorsal horn release of excitatory amino acids in mononeuropathy via GABAergic mechanism. Pain 73,87–95 (1997).
   PubMed Web of Science ®Google Scholar
• Meyerson B, Cui G, Yakhnitsa V et al Modulation of spinal pain mechanisms by spinal cord stimulation and the potential role of adjuvant pharmacotherapy. Stereotac. Funct. Neurosurg. 68(1–4 Pt 1), 129-40(1997).
   Google Scholar
• Meyerson B, Linderoth B. Mechanisms Neurosurg. 68,129-140 (1997) .of spinal cord stimulation in neuropathic pain. Neurolog. Res. 22,285-292 (2000).
   Google Scholar
• Stojanovic M, Abdi S. Spinal cord stimulation. Pain Physician 5 (2), 156–166 (2002).
   PubMedGoogle Scholar
• Wheeler A. Botulinum toxin A, adjunctive therapy for refractory headaches associatedwith pericranial muscle tension. Headache 38(6), 468–471 (1998).
   Google Scholar
• •Reveals the benefits of BTX-A in chronic migraineurs.
   Google Scholar
• Binder W, Brin M, Blitzer A etal Botulinum toxin type A (Botox8) for treatment of migraine headaches: an open-label study. Otolaryng. Head Neck Surgety I 123(6), 669–676 (2000).
   Google Scholar
• Silberstein S, Mathew N, Saper J etal Botulinum toxin type A as a migraine preventative treatment. Headache 40,445–450 (2000).
   PubMed Web of Science ®Google Scholar
• Brin M, Swope D, Abassi S etal Botulinum toxin type A (Botox8) for migraine: a double-blind, placebo-controlled, region specific evaluation. Poster 1196. Headache World 200, London, UK, September 3–7 (2000).
   Google Scholar
• Argoff C. Successful treatment of chronic daily headache with MyoblocTM. Proceedings of the 21st Annual Scientific Meeting of the American Pain Society, Baltimore, MD, USA, March 14–17 (2002).
   Google Scholar
• Opida C. Open-label study of MyoblocTM (botulinum toxin type B) in the treatment of patients with transformed migraine headaches. Proceedings of the 21st Annual Scientific Meeting of the American Pain Society, Baltimore, MD, USA, March 14–17 (2002).
   Google Scholar